Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestyramine for Retinal Effects in Type 2 Diabetes
NCT02249897Phase 4Completed
- Sponsor
- Universidad de Chile
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of cholestyramine in diabetic retinopathy (DR), diabetic neuropathy, sponsored by Universidad de Chile. Started Jan 2015; status: completed.
02
Drugs
cholestyramine
03
Conditions
diabetic retinopathy (DR)diabetic neuropathy
Beyond the preview
Go deeper on NCT02249897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249897.